HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes

Nian Wang,Heng Ma,Jing Li,ChaoYang Meng,Jiang Zou,Hao Wang,Ke Liu,Meidong Liu,Xianzhong Xiao,Huali Zhang,Kangkai Wang
DOI: https://doi.org/10.1016/j.yjmcc.2020.10.010
IF: 5.763
2021-01-01
Journal of Molecular and Cellular Cardiology
Abstract:<p>Palmitic acid (PA)-induced myocardial injury is considered a critical contributor to the development of obesity and type 2 diabetes mellitus (T2DM)-related cardiomyopathy. However, the underlying mechanism <em>has not</em> been fully understood. Here, we demonstrated that PA induced <em>the</em> cell death of H9c2 cardiomyoblasts in a dose- and time-dependent manner, while different ferroptosis inhibitors significantly abrogated the cell death of H9c2 cardiomyoblasts and primary neonatal rat cardiomyocytes exposed to PA. Mechanistically, PA decreased the protein expression <em>levels of both</em> heat shock factor 1 (HSF1) and glutathione peroxidase 4 (GPX4) in a dose- and time-dependent manner, which were restored by different ferroptosis inhibitors. Overexpression of HSF1 not only alleviated PA-induced cell death and lipid peroxidation but also improved disturbed iron homeostasis <em>by</em> regulating the transcription of iron metabolism-related genes (e.g., <em>Fth1</em>, <em>Tfrc</em>, <em>Slc40a1</em>). Additionally, PA-blocked GPX4 protein expression was evidently restored by HSF1 overexpression. Inhibition of endoplasmic reticulum (ER) stress rather than autophagy contributed to HSF1-mediated GPX4 expression. Moreover, GPX4 overexpression protected against PA-induced ferroptosis, whereas knockdown of GPX4 reversed the anti-ferroptotic effect of HSF1. Consistent with the in vitro findings, PA-challenged <em>Hsf</em>1<sup>−/−</sup> mice exhibited more serious ferroptosis, increased <em>Slc40a1</em> and <em>Fth1</em> mRNA expression, decreased GPX4 and TFRC expression <em>and</em> enhanced ER stress in the heart compared with <em>Hsf</em>1<sup>+/+</sup> mice. Altogether, HSF1 may function as a key defender against PA-induced ferroptosis in cardiomyocytes <em>by</em> maintaining cellular iron homeostasis and GPX4 expression.</p>
cardiac & cardiovascular systems,cell biology
What problem does this paper attempt to address?
The paper primarily explores the protective role and potential mechanisms of Heat Shock Factor 1 (HSF1) in palmitic acid (PA)-induced ferroptosis in cardiomyocytes. Research background includes: - Palmitic acid-induced myocardial injury is closely related to the development of obesity and type 2 diabetes-associated cardiomyopathy. - Ferroptosis is a form of programmed cell death distinct from apoptosis and other forms, triggered by the accumulation of lipid peroxides and associated with cardiovascular diseases. - Heat Shock Factor 1 (HSF1) is a stress response transcription factor that plays a role in various cellular stress processes. Research findings: - Palmitic acid induces cell death in a dose- and time-dependent manner in the H9c2 cardiomyocyte cell line and neonatal rat cardiomyocytes. - Palmitic acid reduces the expression levels of HSF1 and Glutathione Peroxidase 4 (GPX4), and this reduction can be reversed by ferroptosis inhibitors. - Overexpression of HSF1 not only alleviates PA-induced cell death and lipid peroxidation but also improves disrupted iron homeostasis by regulating the transcription of iron metabolism-related genes (such as Fth1, Tfrc, and Slc40a1). - HSF1 overexpression also restores the PA-blocked GPX4 protein expression. - Endoplasmic reticulum (ER) stress, rather than autophagy, is involved in HSF1-mediated GPX4 expression. - GPX4 overexpression can protect cells from PA-induced ferroptosis, while GPX4 knockdown reverses the anti-ferroptosis effect of HSF1. - In in vivo experiments, Hsf1 knockout mice treated with palmitic acid exhibited more severe ferroptosis, enhanced ER stress, and altered iron metabolism in the heart compared to wild-type mice. In conclusion, HSF1 may act as a key defensive factor against PA-induced ferroptosis in cardiomyocytes, with mechanisms involving the maintenance of cellular iron homeostasis and GPX4 expression.